Jacob Vincent Micallef, Chief Scientific Officer at VOLITIONRX LTD (VNRX), bought 13,000 shares at $1.70 ($22K) on 2022-09-19, disclosed to the SEC on 2022-09-20.
Open-market purchase of $22k VNRX by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| VNRX | BUY | 2023-08-31 | $25K | — | Filing → |
| VNRX | BUY | 2023-08-28 | $25K | — | Filing → |
| VNRX | BUY | 2022-12-20 | $129K | — | Filing → |